Drugs / Nitrous Oxide-Oxygen
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07618676 | Jun 2025 → Jun 2026 overdue | anxiety | Institute for Oncology and Radiology of Serbia | Recruiting | No outcome recorded |
| — | NCT04199143 | Feb 2020 → Jun 2021 | — | University Hospital, Tours | Completed | No outcome recorded |
| — | NCT02024594 | Oct 2009 → Jul 2010 | anxiety disorder | Mashhad University of Medical Sciences | Completed | No outcome recorded |
| — | NCT01022294 | Jan 2009 → Dec 2011 | dental pulp disorder | University of Aarhus | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nitrousoxide-oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01022294 ↗ |
| Known as | EMONO | “We hypothesized that the antidepressant response to an Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) would be associated with changes in cerebral connectivity and brain...” PMID 37592013 ↗ Aug 2023 |
| Route | Inhaled | “Inhalation of nitrousoxide-oxygen during the first experimental session” NCT01022294 ↗ |